PDC (phosducin)

symbol
PDC
locus group
protein-coding gene
location
1q31.1
gene_family
-
alias symbol
MEKA
alias name
None
entrez id
5132
ensembl gene id
ENSG00000116703
ucsc gene id
uc001gsa.5
refseq accession
NM_022577
hgnc_id
HGNC:8759
approved reserved
1990-04-10
1q31.1
ChineseEnglish

The Pyruvate Dehydrogenase Complex (PDC) is a critical mitochondrial multi-enzyme complex that serves as the metabolic bridge between glycolysis and the tricarboxylic acid (TCA) cycle by catalyzing the oxidative decarboxylation of pyruvate into acetyl-CoA. Comprising three core enzyme subunits—E1 (pyruvate dehydrogenase), E2 (dihydrolipoyl transacetylase), and E3 (dihydrolipoyl dehydrogenase)—the complex relies on a suite of essential cofactors, including thiamine pyrophosphate (TPP), lipoic acid, coenzyme A, FAD, and NAD+, to facilitate its catalytic activity. The functional output of PDC is tightly regulated by a phosphorylation-dephosphorylation cycle, where pyruvate dehydrogenase kinase (PDK) inactivates the complex and pyruvate dehydrogenase phosphatase (PDP) reactivates it, thereby modulating cellular energy flux in response to metabolic demands. Genetic mutations in PDC components, such as PDHA1 and PDHB, result in pyruvate dehydrogenase deficiency, a severe metabolic disorder characterized by lactic acidosis, neurodegeneration, and developmental delays, particularly affecting high-energy tissues like the brain and skeletal muscle. Conversely, dysregulated PDC expression has profound implications for disease pathogenesis; while overexpression can enhance acetyl-CoA supply for lipid synthesis and histone acetylation, it may also precipitate oxidative stress, whereas reduced activity leads to pyruvate accumulation and a shift toward lactate production. This metabolic flexibility is exploited in various pathologies, including diabetes and neurodegenerative diseases, and is central to the Warburg effect in cancer, where tumor cells often suppress PDC activity to sustain aerobic glycolysis. Consequently, understanding the intricate regulation and genetic variability of the PDC family offers significant insights for developing therapeutic strategies targeting metabolic disorders and oncological interventions.

Nucleotide sequence of PDC:[NCBI]
Loading Gene Browser...
Protein Sequence
1MEEAKSQSLE EDFEGQATHT GPKGVINDWR KFKLESQDSD
41SIPPSKKEIL RQMSSPQSRN GKDSKERVSR KMSIQEYELI
81 HKEKEDENC LRKYRRQCMQ DMHQKLSFGP RYGFVYELET
121GKQFLETIEK ELKITTIVVH IYEDGIKGCD ALNSSLTCLA
161A EYPIVKFC KIKASNTGAG DRFSLDVLPT LLIYKGGELI
201SNFISVAEQF AEEFFAGDVE SFLNEYGLLP EREVHVLEHT
241KI EEEDVE
Structure predicted by AlphaFold DB(UniProt: P20941). Color indicates pLDDT confidence (dark blue = high, yellow/orange = low).
SNP variants of PDC:           Showing partial SNPs
rs1799957       rs1929095       rs1929096       rs1988553       rs2070773       rs2737151       rs2774531       rs2774532       rs2976247       rs3124808       rs3737066       rs4007511       rs5779292       rs6659006       rs6659683       rs6672638       rs6672836      
Forward Primer
Forward Tm
Reverse Primer
Reverse Tm
Score
CACATACAGGACCCAAAGGA
60
CTAGGTGGAATTGAATCACTGTC
59
GTCAGCAGAAAGATGAGCA
57
ACGGTATTTACGAAGGCAG
57
AGTCAGCAGAAAGATGAGC
58
ACGGTATTTACGAAGGCAG
58
GTCAGCAGAAAGATGAGCA
58
TACGGTATTTACGAAGGCAG
58
ATTCTCAGGCAAATGTCTTCTC
58
TTGAATGCTCATCTTTCTGCTG
59
CACATACAGGACCCAAAGG
58
TAGGTGGAATTGAATCACTGTC
58
GTCAGCAGAAAGATGAGCA
58
ACGGTATTTACGAAGGCAG
58
ACATACAGGACCCAAAGGAG
59
CTAGGTGGAATTGAATCACTGTC
59
GATTCTCAGGCAAATGTCTTCTC
59
TGAATGCTCATCTTTCTGCTG
59

Subcellular localization of PDC (and its protein):

[UniProt]     [GenomeNet]

" d="M482.414,245.296c3.539,4.293,4.455,10.009,0.202,11 c-4.244,0.996-4.983-10.983-8.293-8.438c-5.271,4.08,9.834,12.271,5.144,17.287c-3.717,3.607-6.172-5.75-10.839-1.976 c-4.673,3.776,6.781,7.299,2.831,11.326c-4.354,4.045-6.979-1.449-9.837-5.517c-1.193-1.742-2.059-3.851-3.595-2.748 c-1.516,1.078-1.854,1.795-0.938,3.666c2.374,4.854,9.235,10.119,5.156,12.535c-5.636,3.346-5.044-8.871-9.426-7.574 c-4.388,1.291,2.557,10.66-1.245,11.141c-4.089,0.545-3.483-10.239-6.979-8.575c-2.522,1.206-0.929,3.071-0.938,4.899 c0.004,1.32-0.964,3.6-2.372,4.062c-3.593,1.171-8.544-1.065-10.251-3.59c-6.04-8.93,0.396-15.997,4.639-7.015 c3.023,4.642,5.182,0.834,2.839-2.219c-1.032-1.354-4.309-5.901-0.781-7.252c2.904-1.113,4.271,1.941,5.985,4.592 c2.61,4.016,5.485,0.117,3.031-3.414c-1.828-2.633-2.74-3.803,3.156-7.42c6.405-4.369,6.52,3.869,10.077,0.646 c2.309-1.832-4.783-5.149,0.06-8.995c2.896-2.293,5.18,6.207,7.961,3.516c3.523-2.737-7.717-7.369,0.117-11.736 C473.413,240.77,480.519,242.891,482.414,245.296z"/> Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
  • plasma membrane
  • cytoplasm
  • extracellular
  • golgi
  • vesicle
  • cytoskeleton
  • endoplasmic reticulum
  • nucleus
  • endosome
  • lysosome
  • mitochondrion

Gene Ontology (GO) terms for PDC:

GO ID
Protein
Source DB
GO:0001750
P20941 (UniProtKB)
IEA
GO:0001917
P20941 (UniProtKB)
IEA
GO:0004859
P20941 (UniProtKB)
TAS
GO:0005634
P20941 (UniProtKB)
IEA
GO:0005737
P20941 (UniProtKB)
IBA
GO:0005829
P20941 (UniProtKB)
IEA
GO:0007186
P20941 (UniProtKB)
TAS
GO:0007601
P20941 (UniProtKB)
IEA
GO:0007602
P20941 (UniProtKB)
TAS
GO:0008616
P20941 (UniProtKB)
IBA
GO:0043086
P20941 (UniProtKB)
IEA
GO:0008479
P20941 (UniProtKB)
IBA

microRNAs potentially regulating PDC:     

String
BioGrid
mentha
Loading…
Interacting Gene Interaction Source/Score
Disease Score NofPmids NofSnps Source
Disease Score NofPmids NofSnps Source
Retinitis Pigmentosa 0.002909916 2 0 BeFree_GAD
Blind Vision 0.00272435 1 0 LHGDN
Schizophrenia 0.002367032 1 1 GAD
Hypertensive disease 0.001628651 6 1 BeFree
Retinal Diseases 0.000542884 2 0 BeFree
Amyotrophic Lateral Sclerosis 0.000542884 2 0 BeFree
Polycythemia 0.000542884 2 0 BeFree
Dementia 0.000542884 2 0 BeFree
leukemia 0.000542884 2 0 BeFree
Primary biliary cirrhosis 0.000542884 2 0 BeFree
Optimizing peritoneal dialysis access: a propensity score-matched comparison of open, multi-port, and single-port laparoscopic catheter insertion.
Rompianesi G, Montalti R, Campanile S, Papadakis G, Cox MA, Chatziisaak D, Benassai G, Loiaco G, George A, Pisani A, Burri P, Paribello G, Riccio E, Sordoni G, Troisi R, Vrakas G Surg Endosc IF: 3.3 2026-07-13
Defects in ethanol fermentation catalysed by pyruvate decarboxylases reduce arsenic levels in rice.
Hayashi S, Tanikawa H, Kuramata M, Abe T, Ishikawa S J Exp Bot IF: 6.5 2026-01-12
Immune Profiling the Axilla with Fine Needle Aspiration Is Feasible to Risk-Stratify Breast Cancer.
Gore JA, Llewellyn AM, Lam CYR, Shields JD, Naidoo K Cancers (Basel) IF: 4.4 2026-01-14
MOF-derived C/SiOC ceramic aerogels with high strength and excellent microwave absorption performance.
Ren S, Shui A, Qian J, Song K, Yu H, He C, Tanaka S J Colloid Interface Sci IF: 9.6 2026-12-15
Comparative Effects of Thymoquinone, Tranexamic Acid, and Porcine Dermal Collagen on Seroma Formation and Tissue Remodeling After Mastectomy in a Rat Model.
Duran A, Hacioglu N, Turkoglu Dulger A, Kockar F, Tokay E, Altun E, Cay F, Sahin AG, Pulat H, Basbug M Medicina (Kaunas) IF: 2.9 2026-06-24
Reporting of pregnancy vaccinations across two data sources, New South Wales, Australia, 2017-2022.
Sonneveld N, Wilson E, Ennis S, McRae J, Macartney K, Liu B Public Health Res Pract IF: 2.2 2026-03-26

Loading comments...

Log in to post comments Log In Sign Up

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com